RxDoctor Payments Data

Cassie Vaughn, PA

Physician Assistant · Barbourville, KYNPI 1386274850

Payments from drug & device makers

$2,479in general payments, 2019–2025

Across 165 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$598
  • Novo Nordisk$297
  • Bayer$249
  • AstraZeneca$216
  • AbbVie$177
  • Biohaven Pharmaceutical Holding Company Ltd.$171
  • plus $772 from 16 others

What the payments were for

  • Food & beverage$2,479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,479 in reported general payments places this provider in the 80th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,188
Medicare patients
21
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$61,173
OzempicSemaglutide38$40,438
JardianceEmpagliflozin22$25,796
EliquisApixaban19$20,765
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$12,362
EntrestoSacubitril/Valsartan12$9,735
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,058
Ventolin HfaAlbuterol Sulfate20$1,504
Levothyroxine Sodium58$1,396
Albuterol Sulfate HfaAlbuterol Sulfate47$1,135
Gabapentin98$798
Ondansetron OdtOndansetron18$699
Nystatin14$696
Diclofenac Sodium26$517
Esomeprazole Magnesium20$464

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$598$61,17359 claims
Novo NordiskOzempic$297$40,43838 claims
PfizerEliquis$70$20,76519 claims
AstraZenecaBreztri Aerosphere$216$12,36220 claims
GSKTrelegy Ellipta$14$9,05814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Barbourville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →